World's Best Scientists 2026 revealed!
Philippe Mathurin

Philippe Mathurin

D-Index & Metrics

Medicine

D-Index
101
Citations
46656
World Ranking
7859
National Ranking
240

Philippe Mathurin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Philippe Mathurin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 536 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Philippe Mathurin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Philippe Mathurin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Philippe Mathurin is a researcher affiliated with the University of Lille in France. Their work primarily focuses on the field of Medicine, specifically within subfields such as Epidemiology, Hepatology, Pathology and Forensic Medicine, Surgery, and Endocrinology, Diabetes and Metabolism. The scientist's research covers several topics including Liver Disease Diagnosis and Treatment, Alcohol Consumption and Health Effects, Liver Disease and Transplantation, Hepatitis C virus research, Hepatocellular Carcinoma Treatment and Prognosis, Hepatitis B Virus Studies, and Diet, Metabolism, and Disease.

Their publication record includes a number of articles in well-recognized journals with a significant concentration in hepatology-related venues. Frequent publication outlets include:

  • Journal of Hepatology
  • Hepatology
  • JHEP Reports
  • Liver International
  • UNC Libraries

Recent significant papers authored or co-authored by Philippe Mathurin include:

  • Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis, 2020, Gastroenterology
  • Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors, 2022, Nature Reviews Gastroenterology & Hepatology
  • Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials, 2020, Journal of Hepatology
  • Diagnosis and Treatment of Alcohol-Associated Liver Disease, 2021, JAMA
  • Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta, 2020, Journal of Hepatology

The scientist collaborates frequently with a set of co-authors, with the highest number of joint publications involving:

  • Alexandre Louvet
  • Guillaume Lassailly
  • Sébastien Dharancy
  • Victor de Lédinghen
  • Fabien Zoulim

Best Publications

  • Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa

  • Early Liver Transplantation for Severe Alcoholic Hepatitis

    Philippe Mathurin;Christophe Moreno;Didier Samuel;Jérôme Dumortier

  • Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

    T Poynard;V Leroy;M Cohard;T Thevenot

  • Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

    Yi Duan;Yi Duan;Cristina Llorente;Cristina Llorente;Sonja Lang;Katharina Brandl

  • EASL Clinical Practice Guidelines: Management of alcohol-related liver disease

    Mark Thursz;Antoni Gual;Caroline Lackner;Philippe Mathurin

  • Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients

    Guillaume Lassailly;Robert Caiazzo;David Buob;Marie Pigeyre

  • Impact of hepatitis B and C virus on kidney transplantation outcome

    Philippe Mathurin;Catherine Mouquet;Thierry Poynard;Cheickna Sylla

  • CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)

    T. Yau;J.W. Park;R.S. Finn;A.-L. Cheng

  • A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.

    T Poynard;P Bedossa;M Chevallier;P Mathurin

  • Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study

    Josep M. Llovet;Thomas Decaens;Jean-Luc Raoul;Eveline Boucher

  • Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial

    Rafael Bañares;Rafael Bañares;Frederik Nevens;Fin Stolze Larsen;Rajiv Jalan

  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

    Fabrice Carrat;Hélène Fontaine;Céline Dorival;Mélanie Simony

  • A comparison of fibrosis progression in chronic liver diseases

    Thierry Poynard;Philippe Mathurin;Ching-Lung Lai;Dominique Guyader

  • A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

    Christophe Corpechot;Olivier Chazouillères;Alexandra Rousseau;Antonia Le Gruyer

  • Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

    Pierre Nahon;Pierre Nahon;Valérie Bourcier;Richard Layese;Etienne Audureau

  • Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease

    Philippe Mathurin;Antoine Hollebecque;Laurent Arnalsteen;David Buob

  • A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.

    Sylvie Naveau;Sylvie Chollet-Martin;Sébastien Dharancy;Philippe Mathurin

  • Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data

    Philippe Mathurin;John O'Grady;Robert L. Carithers;Martin Phillips

  • A randomized trial of prednisolone in patients with severe alcoholic hepatitis.

    Marie-José Ramond;Thierry Poynard;Bernard Rueff;Philippe Mathurin

  • Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia

    David W. Crabb;Ramon Bataller;Naga P. Chalasani;Patrick S. Kamath

Frequent Co-Authors

Victor de Ledinghen
Victor de Ledinghen Grenoble Alpes University
Jean-Pierre Bronowicki
Jean-Pierre Bronowicki University Hospital of Nancy
Dominique Larrey
Dominique Larrey University of Montpellier
Albert Tran
Albert Tran Inserm : Institut national de la santé et de la recherche médicale
Stanislas Pol
Stanislas Pol Université Paris Cité
Marc Bourlière
Marc Bourlière Hôpital Saint Joseph
Thierry Poynard
Thierry Poynard Sorbonne University
Paul Calès
Paul Calès University of Angers
Laurent Alric
Laurent Alric Federal University of Toulouse Midi-Pyrénées

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering studying Medicine in the USA, exploring related online degrees can open up diverse career opportunities in healthcare. For those interested in leadership roles, earning a bachelors in healthcare administration provides an affordable entry point into healthcare management and operations.

Advancing further, the cheapest mha programs offer flexible options to develop advanced leadership skills essential for higher-level administrative positions in hospitals, clinics, and public health organizations.

Clinical careers also benefit from affordable online pathways. The cheapest dnp programs are designed for nurses aiming for the highest level of clinical practice, while online pharmacy schools allow students to earn a doctorate in pharmacy remotely and conveniently.

Each of these accredited online programs can help shape a rewarding career in healthcare, offering both flexibility and cost-effectiveness for students in the US and beyond.

Best Scientists Citing Philippe Mathurin

Trending Scientists

Recently Published Articles